Last Updated on October 9, 2024 by The Health Master
Sanofi India has received marketing authorisation for its diabetes drug Soliqua (in pre-filled pen) from the Central Drugs Standard Control Organization (CDSCO).
Soliqua is indicated as treatment to improve glycemic control as an adjunct to diet and exercise, in adults with obesity and type 2 diabetes who are insufficiently controlled on oral or injectable therapies.
It comes in once daily dosing of pre-filled pens in fixed-ratio combination (10-40 and 30-60) of insulin glargine and lixisenatide.
Cyrus Aibara, Head – Diabetes Business Unit, Sanofi (India) said, “With approximately 74 million Indians* (between the ages of 20-79 years) living with diabetes, healthcare professionals need more treatment options to customize diabetes care for them.
Soliqua is the latest addition to our comprehensive diabetes portfolio (OADs and insulins) indicated for people with obesity who are living with insufficiently controlled diabetes. It will allow physicians to provide more tailored solutions for better diabetes management.”
Dr. Shalini Menon, Country Medical Lead, Sanofi (India) said,“Concerns about hypoglycemia and weight gain are known barriers when advancing diabetes treatments, more so when intensifying to a complex insulin regime.
The global Solimix study that included Indian patients, demonstrated that once daily Soliqua™ provides with weight benefit and less hypoglycaemia when compared with twice daily premixed insulin – thereby becoming a valuable option for endocrinologists.”
Soliqua (10-40 and 30-60 prefilled pens) is a once-daily injectable combination drug containing insulin glargine 100 Units/ml, which is a long-acting basal insulin and lixisenatide, a GLP-1 receptor agonist.
CDSCO has approved 30 Medical Devices Testing Laboratories till now
CDSCO gives approval for this Medical Watch
CDSCO panel gives nod for Icosapent Ethyl Capsules
CDSCO Panel nod for Cholecalciferol Aqueous Injection
CDSCO panel gives nod for Phase III Clinical Trial of FDC Salicylic Acid Plus…
Remdesivir not a wonder drug, affects heart: Study
USFDA gives approval for Obeticholic acid tablets
Drug recall: 55,000 bottles of Colchicine tablets due to this reason
Drug Control Dept launches WhatsApp helpline number: Tamil Nadu
Proposal to regulate prices of non-scheduled drugs under consideration
Govt Job: For B.Pharm as Bench Chemist at CDSCO
Difference: Disintegration and Dissolution test in pharma industry
How to prepare SOPs in the Pharma Industry
Difference between branded and generic medicines
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
